Littérature scientifique sur le sujet « Autoimmune systemic diseases »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Autoimmune systemic diseases ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Autoimmune systemic diseases"
Shi, Guixiu, Jianying Zhang, Zhixin (Jason) Zhang et Xuan Zhang. « Systemic Autoimmune Diseases ». Clinical and Developmental Immunology 2013 (2013) : 1–2. http://dx.doi.org/10.1155/2013/728574.
Texte intégralRipoll, E., E. Ripoll, M. Goma, N. Bolanos, I. Herrero, O. Bestard, J. M. Cruzado et al. « Autoimmune systemic diseases ». Nephrology Dialysis Transplantation 27, suppl 2 (1 mai 2012) : ii61—ii62. http://dx.doi.org/10.1093/ndt/gfs205.
Texte intégralDelgadillo, Xavier, Adrián E. Ortega et Alejandro Moreira Greco. « Systemic and Autoimmune Diseases ». Clinics in Colon and Rectal Surgery 32, no 05 (septembre 2019) : 372–76. http://dx.doi.org/10.1055/s-0039-1687833.
Texte intégralShi, Guixiu, Jianying Zhang, Zhixin (Jason) Zhang et Xuan Zhang. « Systemic Autoimmune Diseases 2014 ». Journal of Immunology Research 2015 (2015) : 1–2. http://dx.doi.org/10.1155/2015/183591.
Texte intégralCavestro, Cinzia, et Marcella Ferrero. « Migraine in Systemic Autoimmune Diseases ». Endocrine, Metabolic & ; Immune Disorders - Drug Targets 18, no 2 (13 février 2018) : 124–34. http://dx.doi.org/10.2174/1871530317666171124124340.
Texte intégralRoyer, Mathieu, et Xavier Puéchal. « Mucormycosis in systemic autoimmune diseases ». Joint Bone Spine 81, no 4 (juillet 2014) : 303–7. http://dx.doi.org/10.1016/j.jbspin.2014.01.002.
Texte intégralKallenberg, Cees G. M. « Etiopathogenesis of systemic autoimmune diseases ». Current Opinion in Rheumatology 25, no 2 (mars 2013) : 223–24. http://dx.doi.org/10.1097/bor.0b013e32835cf2d1.
Texte intégralWang, Chrong-Reen, et Hung-Wen Tsai. « Autoimmune liver diseases in systemic rheumatic diseases ». World Journal of Gastroenterology 28, no 23 (21 juin 2022) : 2527–45. http://dx.doi.org/10.3748/wjg.v28.i23.2527.
Texte intégralTerzin, Viktória. « Association between autoimmune pancreatitis and systemic autoimmune diseases ». World Journal of Gastroenterology 18, no 21 (2012) : 2649. http://dx.doi.org/10.3748/wjg.v18.i21.2649.
Texte intégralRalli, Massimo, Vittorio D’Aguanno, Arianna Di Stadio, Armando De Virgilio, Adelchi Croce, Lucia Longo, Antonio Greco et Marco de Vincentiis. « Audiovestibular Symptoms in Systemic Autoimmune Diseases ». Journal of Immunology Research 2018 (19 août 2018) : 1–14. http://dx.doi.org/10.1155/2018/5798103.
Texte intégralThèses sur le sujet "Autoimmune systemic diseases"
Leeuw, Karina de. « Premature atherosclerosis in systemic autoimmune diseases ». [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2008. http://irs.ub.rug.nl/ppn/.
Texte intégralLövgren, Tanja. « Endogenous type I interferon inducers in systemic autoimmune diseases / ». Uppsala : Acta Universitatis Upsaliensis, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7181.
Texte intégralLövgren, Tanja. « Endogenous Type I Interferon Inducers in Systemic Autoimmune Diseases ». Doctoral thesis, Uppsala University, Department of Medical Sciences, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7181.
Texte intégralPatients with systemic lupus erythematosus (SLE) have elevated levels of interferon (IFN)-α in blood and IFN-α-producing cells in tissues. In the present thesis, we investigate the mechanisms behind the upregulated IFN-α-production in SLE and also show that the IFN-α system is activated in primary Sjögren’s syndrome (pSS), with IFN-α-producing cells in the major affected organ, the salivary glands. The IFN-α is a type I IFN, a family of cytokines counteracting especially viral infections, by acting directly on infected cells, and via many immunomodulatory effects. The latter may also contribute to autoimmune processes.
The type I IFNs are usually produced upon recognition of microbial structures. In SLE, however, DNA-containing immune complexes (ICs) that induce IFN-α production are found. Many autoantibodies in SLE and pSS are directed to nucleic acids or to DNA/RNA-binding proteins. We show that also RNA in complex with autoantibodies from SLE or pSS patients (RNA-IC) induces IFN-α-production. The RNA could be either in the form of RNA-containing material released from apoptotic or necrotic cells or as a pure RNA-containing autoantigen, the U1 small nuclear ribonucleoprotein particle.
The IFN-α-production induced by RNA-IC occurred in plasmacytoid dendritic cells (PDCs), also termed natural IFN-producing cells (NIPCs), via binding to Fcγ-receptor IIa, endocytosis and triggering of Toll-like receptors (TLRs), probably TLR7 and TLR9. The RNA-IC may also have other effects, and we found that they induce prostaglandin E2 (PGE2) production in monocytes and tumor necrosis factor (TNF)-α in both monocytes and NIPC/PDC. The PGE2 downregulated the IFN-α induction in NIPC/PDC, and the IFN-α induction was increased in monocyte-depleted cell cultures.
The findings presented in this thesis aids in the understanding of the mechanisms behind the activated IFN-α system in SLE and other autoimmune diseases, and shows that also pSS is one of these diseases.
Dumoitier, Nicolas. « Analysis of B lymphocytes in systemic autoimmune vascular diseases ». Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCC304.
Texte intégralTolerance mechanisms allow the negative selection of auto-reactive B lymphocytes while protecting the positive selection and differentiation of plasmocytes that produce high affinity antibodies. Tolerance mechanisms are altered in various auto-immune diseases and allow the production of auto-antibodies. Indeed, therapeutic targeting of autoreactive B lymphocytes, notably using anti-CD20 monoclonal antibodies, gives promising results in several auto-immune pathologies. While these treatments show a relative efficacy in anti-neutrophil cytoplasmic antibodies associated vasculitis (ANCA) (AAV), other autoimmune diseases with vascular components, among which systemic sclerosis (SSc) or idiopathic high blood pressure (iPAH), remain resistant to the targeting. Previous studies have essentially addressed the characterization of auto-antibodies producing B cells sub-populations. Therefore, this thesis project aimed at delineating phenotypic and functional characterization of the lymphocytic B cells sub-populations involved in these various vascular autoimmune diseases.Patients affected by Granulomatosis with polyangiitis presented with important activation of innate immune system altogether with an increased production of IL6 by B lymphocytes correlated with T lymphocytes activation. Phenotypic alterations of B lymphocytes were observed for AAV patients, notably with MPA, suggesting an autoimmune component. Expression of CD69, CD95 and IL-6- receptor allowed discrimination between the various forms of the disease. In SSc, with particular emphasis in the most severe, diffuse forms, and in the associated PAH, a basal activation of the B cells was observed, allowing an important secretion of IL-6 and TGF-ß1. The latter contributed to the proliferation of fibroblasts and to the secretion of collagen, responsible for fibrosis induction as observed in the pathology. Finally, presence of activated basophils in SSc also participates in the activation of B cells and fibroblasts. These results place B lymphocytes, besides their role in antibody production, as important pathophysiological players through the secretion of pro-inflammatory and pro-fibrotic cytokines such as IL-6 and TGF-ß which are both implicated in endothelial cells activation in autoimmune vascular diseases
Imgenberg-Kreuz, Juliana. « Epigenetic and Gene Expression Signatures in Systemic Inflammatory Autoimmune Diseases ». Doctoral thesis, Uppsala universitet, Molekylär medicin, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-310388.
Texte intégralAtta, Mustafa S. « Investigation of the humoral and cellular features of autoimmune diseases ». Thesis, University of Nottingham, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.281586.
Texte intégralWang, Chuan. « DNA Sequence Variants in Human Autoimmune Diseases ». Doctoral thesis, Uppsala universitet, Molekylär medicin, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-179189.
Texte intégralMcCormick, Natalie. « The health resource utilization and economic burden of systemic autoimmune rheumatic diseases ». Thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/42149.
Texte intégralDuffy, Emeir. « An investigation of the influence of dietary supplementation of n-3 fish oil and/or copper on systemic lupus erythematosus ». Thesis, University of Ulster, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.273795.
Texte intégralEsfandiari, Ehsanollah. « Role of Th1 and Th2 cytokines in the pathogenesis of systemic autoimmune diseases ». Thesis, University of Glasgow, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.366255.
Texte intégralLivres sur le sujet "Autoimmune systemic diseases"
Rolando, Cimaz, et Lehman Thomas J. A, dir. Pediatrics in systemic autoimmune diseases. Amsterdam : Elsevier, 2008.
Trouver le texte intégralU, Wells A., et Denton C. P, dir. Pulmonary involvement in systemic autoimmune diseases. Amsterdam : Elsevier, 2004.
Trouver le texte intégralservice), ScienceDirect (Online, dir. Digestive involvement in systemic autoimmune diseases. Amsterdam : Elsevier, 2008.
Trouver le texte intégralservice), ScienceDirect (Online, dir. Antiphospholipid syndrome in systemic autoimmune diseases. Amsterdam : Elsevier, 2009.
Trouver le texte intégralPiercarlo, Sarzi-Puttini, dir. The skin in systemic autoimmune diseases. Amsterdam : Elsevier, 2006.
Trouver le texte intégralA, Doria, et Pauletto Paolo 1947-, dir. The heart in systemic autoimmune diseases. Amsterdam : Elsevier, 2004.
Trouver le texte intégralWalker, Sara, et Luis J. Jara. Endocrine manifestations of systemic autoimmune diseases. Amsterdam : Elsevier Science, 2008.
Trouver le texte intégralA, Asherson Ronald, dir. Vascular manifestations of systemic autoimmune diseases. Boca Raton : CRC Press, 2001.
Trouver le texte intégral1937-, Cruse J. M., et Lewis R. E. 1947-, dir. Autoimmunity : Basis concepts , systemic and selectedorgan-specific diseases. Basel : Karger, 1985.
Trouver le texte intégral1937-, Cruse Julius M., et Lewis R. E. 1947-, dir. Autoimmunity : Basis concepts : systemic and selected organ-specific diseases. Basel : Karger, 1985.
Trouver le texte intégralChapitres de livres sur le sujet "Autoimmune systemic diseases"
Townsend, Henry B., Anthony M. Turkiewicz et Xena A. Whittier. « Systemic Corticosteroids ». Dans Autoimmune Bullous Diseases, 233–41. Cham : Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26728-9_13.
Texte intégralPetri, Michelle. « Life-Threatening Complications of Systemic Lupus Erythematosus ». Dans Autoimmune Diseases, 9–17. London : Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-358-9_2.
Texte intégralQuillinan, Niamh P., et Christopher P. Denton. « Systemic Sclerosis : Severe Involvement of Internal Organs ». Dans Autoimmune Diseases, 67–88. London : Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-358-9_6.
Texte intégralJonkman, Marcel F., et J. M. Meijer. « Bullous Systemic Lupus Erythematosus ». Dans Autoimmune Bullous Diseases, 137–41. Cham : Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-91557-5_17.
Texte intégralJonkman, Marcel F. « Bullous Systemic Lupus Erythematosus ». Dans Autoimmune Bullous Diseases, 151–56. Cham : Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23754-1_17.
Texte intégralRuiz-Irastorza, Guillermo, et Munther A. Khamashta. « Complicated Pregnancies in Patients with Autoimmune Systemic Diseases ». Dans Autoimmune Diseases, 331–44. London : Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-358-9_20.
Texte intégralWalker, Jennifer G., et Marvin J. Fritzler. « Systemic Sclerosis ». Dans Diagnostic Criteria in Autoimmune Diseases, 31–36. Totowa, NJ : Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-285-8_6.
Texte intégralLópez-Isac, Elena, Marialbert Acosta-Herrera et Javier Martín. « Systemic Sclerosis ». Dans Genetics of Rare Autoimmune Diseases, 19–35. Cham : Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03934-9_2.
Texte intégralLaskaris, George, et Crispian Scully. « Autoimmune Diseases ». Dans Periodontal Manifestations of Local and Systemic Diseases, 245–57. Berlin, Heidelberg : Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55596-1_23.
Texte intégralBertolaccini, Maria Laura, Graham R. V. Hughes et Munther A. Khamashta. « Systemic Lupus Erythematosus ». Dans Diagnostic Criteria in Autoimmune Diseases, 3–8. Totowa, NJ : Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-285-8_1.
Texte intégralActes de conférences sur le sujet "Autoimmune systemic diseases"
KCHIR, hela, Dhouha Cherif, Dhilel Issaoui, Maha Mtir, Dhia Kaffel, Faten Limaiem et Nadia Maamouri. « SAT0195 SYSTEMIC DISEASES ASSOCIATED WITH AUTOIMMUNE LIVER DISEASES ». Dans Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8246.
Texte intégralFeijoo, ML Velloso, N. Plaza Aulestia, S. Rodriguez Montero et JL Marenco de la Fuente. « AB0459 Treatment of systemic autoimmune diseases with rituximab : safety data ». Dans Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3890.
Texte intégralGinosyan, K., A. Beglaryan et V. Vardanyan. « AB0983 Mefv mutations in armenian patients with systemic autoimmune diseases ». Dans Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.5109.
Texte intégralPriori, R., F. Conti, E. Cassarà, E. Medda, MA Stazi, R. Gerli, A. Manfredi, F. Franceschini, MG Danieli et G. Valesini. « THU0248 Familial clustering of systemic lupus erythematosus with other autoimmune diseases ». Dans Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.792.
Texte intégralVilariño Seijas, A., A. Morales Triadó, L. Carabias Ané, G. Cardona Peitx, E. Valls Sánchez, C. Codina Jiménez et C. Quiñones Ribas. « 5PSQ-053 Off-label use of rituximab in systemic autoimmune diseases ». Dans 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.370.
Texte intégralFeijoo, ML Velloso, S. Rodriguez Montero, N. Plaza Aulestia et JL Marenco de la Fuente. « AB0458 B cells depletion for the treatment of systemic autoimmune diseases ». Dans Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.6402.
Texte intégralBarturen, Guillermo, Sepideh Babaei, Francesc Català-Moll, Manuel Martínez-Bueno, Zuzanna Makowska, Jordi Martorell-Marugán, Pedro Carmona-Sáez et al. « O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases ». Dans 12th European Lupus Meeting. Lupus Foundation of America, 2020. http://dx.doi.org/10.1136/lupus-2020-eurolupus.42.
Texte intégralPelegrin, L., J. Hernández-Rodríguez, J. Torras, G. Espinosa, A. Adán et M. T. Sainz. « AB0678 Peripheral ulcerative keratitis associated to autoimmune systemic diseases : visual prognosis and occurrence while systemic disease in remission ». Dans Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.4334.
Texte intégralLing, JES, M. Ter Wee, W. Lems, M. Nurmohamed et H. Raterman. « SAT0695 No association between vitamin d levels and cardiovascular diseases in inflammatory joint diseases and systemic autoimmune diseases – a systematic review ». Dans Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4302.
Texte intégralAcosta-Herrera, M., M. Kerick, D. Gonzalez-Serna, C. Wijmenga, A. Franke, L. Padyukov, T. Vyse et al. « OP0283 Cross-disease meta-analysis in four systemic autoimmune diseases to identify shared genetic etiologies ». Dans Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.2876.
Texte intégralRapports d'organisations sur le sujet "Autoimmune systemic diseases"
Li, Mingqiang, Juan Wan et Zhenhong Xu. The association between Parkinson’s disease and autoimmune diseases : a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, août 2022. http://dx.doi.org/10.37766/inplasy2022.8.0088.
Texte intégralGong, Boshen, Fanrui Meng et Yang Yang. Association Between Gut Microbiota and Autoimmune Thyroid Disease : A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, avril 2021. http://dx.doi.org/10.37766/inplasy2021.4.0135.
Texte intégralRäber, Miro E., Dilara Sahin, Ufuk Karakus et Onur Boyman. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, novembre 2022. http://dx.doi.org/10.37766/inplasy2022.11.0086.
Texte intégralLiu, Miao, Hongan Wang, Jing Lu, Zhiyue Zhu, Chaoqun Song, Ye Tian, Xinzhi Chen et al. Vitamin D supplementation in the treatment of Myasthenia Gravis A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, septembre 2022. http://dx.doi.org/10.37766/inplasy2022.9.0129.
Texte intégralTimm, Eliane, Julia Vieregg et Ursula Wolf. Movement based mindfulness therapies in patients with multiple sclerosis – a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, février 2022. http://dx.doi.org/10.37766/inplasy2022.2.0102.
Texte intégralZhang, Yingrong, Sanchun Tan, Jieyu Wang, Yanji Zhang, Mengyuan Huang, Hongjie Xia, Yaxin Hu, Yinyue Rao et Zhongyu Zhou. A scoping review protocol of systematic reviews and meta-analyses to acupuncture for the treatment of peripheral facial paralysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, mars 2022. http://dx.doi.org/10.37766/inplasy2022.3.0084.
Texte intégral